Article Text
PDF
Statistics from Altmetric.com
OpenUrlCrossRefPubMedWeb of Science
Q Does mirtazapine improve symptoms and quality of life in women with social phobia?
METHODS
Design:
Randomised controlled trial.
Allocation:
Concealed.
Blinding:
Double blind.
Follow up period:
10 weeks.
Setting:
General population, Germany; September to December 2004.
Patients:
66 women with social phobia (DSM-IV). Exclusions: <18 years old; psychosis; severe major depressive episode; pregnancy; not using contraception; psychotherapy; suicidal; abusing drugs or alcohol; other illness; or current use of mirtazapine or other psychotropics.
Intervention:
Mirtazapine (30 mg/day); placebo.
Outcomes:
Social anxiety (Social Phobia Inventory (SPIN); Liebowitz Social …
Footnotes
For correspondence: Dr Marius Nickel, Inntalklinik, 84359 Simbach am Inn, Germany; m.nickel{at}inntalklinik.de
Source of funding: Not stated.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.